Autophagy degrades immunogenic endogenous retroelements induced by 5-azacytidine in acute myeloid leukemia

Author:

Noronha NanditaORCID,Durette ChantalORCID,Silva Bianca EORCID,Courtois JustineORCID,Humeau JulietteORCID,Sauvat Allan,Hardy Marie-PierreORCID,Vincent KrystelORCID,Laverdure Jean-PhilippeORCID,Lanoix JoëlORCID,Baron FrédéricORCID,Thibault PierreORCID,Perreault ClaudeORCID,Ehx GregoryORCID

Abstract

ABSTRACTThe hypomethylating agent 5-azacytidine (AZA) is the first-line therapy for acute myeloid leukemia (AML) patients unfit for intensive chemotherapy. Evidence suggests that the anti-tumor effect of AZA results partly from T-cell cytotoxic responses against MHC-I-associated peptides (MAPs) whose expression is induced by hypomethylation. Through a proteogenomic approach, we analyzed the impact of AZA on the transcriptome and MAP repertoire of four AML cell lines and validated salient findings in the transcriptome of 437 primary AML samples. We demonstrate that AZA caused pleiotropic changes in AML cells via perturbation of transcription, translation, and protein degradation. Overall, 1,364 MAPs were upregulated in AZA-treated cells, including several cancer-testis antigens. Increased MAP abundance was due to the upregulation of corresponding transcripts in a minority of cases and post-translational events in most cases. Furthermore, AZA-induced hypomethylation increased the abundance of numerous transcripts, of which 38% were endogenous retroelements (EREs). Upregulated ERE transcripts triggered innate immune responses but were degraded by autophagy and not processed into MAPs. Autophagy resulted from the formation of protein aggregates caused by AZA-dependent inhibition of DNMT2, a tRNA-methyl transferase enzyme. We found that autophagy inhibition had a synergistic effect with AZA on AML cell proliferation and survival, increased ERE levels and triggered pro-inflammatory responses. Finally, autophagy gene signatures were associated with a lower abundance of CD8+T-cell markers in AML patients expressing high levels of EREs. Altogether, this work demonstrates that the impact of AZA is regulated at several levels and suggests that inhibiting autophagy could improve the immune recognition of AML blasts in patients.

Publisher

Cold Spring Harbor Laboratory

Reference67 articles.

1. Origins of aberrant DNA methylation in acute myeloid leukemia

2. Aberrant CpG island methylation in acute myeloid leukemia is accentuated at relapse;Blood, The Journal of the American Society of Hematology,2008

3. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN;Blood, The Journal of the American Society of Hematology,2022

4. Different mechanisms of drug resistance to hypomethylating agents in the treatment of myelodysplastic syndromes and acute myeloid leukemia;Drug Resist Updat,2022

5. Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3